Literature DB >> 9311588

Immunohistochemical studies on Waf1p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in northern China.

G Yang1, Z Zhang, J Liao, D Seril, L Wang, S Goldstein, C S Yang.   

Abstract

To better understand the roles of p53 and cell cycle-regulating protein alterations in human esophageal carcinogenesis, we investigated immunohistochemically the distribution patterns of Waf1p21, pRb, p16 and p53 in 22 cases of surgically resected esophageal cancer as well as in the neighboring non-cancerous squamous epithelia. Waf1p21 protein was detected in 13 of the 20 cases of well-differentiated squamous-cell carcinoma (SCC), where the Waf1p21-positive cells were located mainly in the interior layers of the cancer nests. Conversely, p53-positive cells were found mostly in the peripheral layers. Cells containing both Waf1p21- and p53-positive immunostaining were not observed in a double-immunostaining experiment. p16 was detected in both the nucleus and cytoplasm in 3 of the 22 cases of SCC. All of these p16-positive cancers showed an absence of pRb immunostaining; this result is consistent with the idea that expression of p16 is regulated negatively by pRb. Eleven of the 22 esophageal SCCs (50%) showed extensive pRb immunostaining cells, and the remaining 11 cases displayed a few pRb-positive cells or an absence of pRb immunostaining. In a majority of the morphologically normal squamous-cell epithelia samples, immunostaining of Waf1p21 and pRb was found in most of the cells in the parabasal layers (proliferation compartment), where PCNA-positive cells also resided. In the pre-cancerous lesions, Waf1p21 and pRb were detected in cells surrounding the top of the lesioned region, p16-positive cells were scattered in the basal cell hyperplastic and dysplastic lesions and p53-positive cells existed in 2 distinct patterns: "scattered" and "focal".

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311588     DOI: 10.1002/(sici)1097-0215(19970904)72:5<746::aid-ijc7>3.0.co;2-s

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients.

Authors:  Noushin Taghavi; Firouzeh Biramijamal; Masoud Sotoudeh; Omeed Moaven; Hooman Khademi; Mohammad Reza Abbaszadegan; Reza Malekzadeh
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

2.  Expression of Smad4, TGF-βRII, and p21waf1 in esophageal squamous cell carcinoma tissue.

Authors:  Hui Cheng; Cheng Chen; L U Liu; N A Zhan; Benhui Li
Journal:  Oncol Lett       Date:  2015-04-23       Impact factor: 2.967

Review 3.  Methylation in esophageal carcinogenesis.

Authors:  Da-Long Wu; Feng-Ying Sui; Xiao-Ming Jiang; Xiao-Hong Jiang
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

4.  p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma.

Authors:  G Busatto; Y H Shiao; A R Parenti; R Baffa; A Ruol; M Plebani; M Rugge
Journal:  Mol Pathol       Date:  1998-04

5.  Differences in proximal (cardia) versus distal (antral) gastric carcinogenesis via the retinoblastoma pathway.

Authors:  Christian Gulmann; Helen Hegarty; Antoinette Grace; Mary Leader; Stephen Patchett; Elaine Kay
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

6.  Impact of alcohol dehydrogenase gene 4 polymorphisms on esophageal squamous cell carcinoma risk in a Chinese population.

Authors:  Xiaoling Xu; Jiwen Wang; Shuang-Mei Zhu; Ming Yang; Yun Fang; An Zhao; Qian Song; Weimin Mao
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.